Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Folashade Otegbeye

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Transplantation and Cellular Therapy|May 6, 2022
Bench at Bedside Models Facilitate CAR-T Cell Supply ChainFolashade Otegbeye
Revista Brasileira De Hematologia E Hemoterapia|August 24, 2017
Understanding population-wide haplotype frequencies of human leukocyte antigen (HLA) alleles in linkage disequilibrium is important for hematopoietic stem cell transplantationFolashade Otegbeye
Frontiers in Immunology|January 9, 2024
Optimizing the cryopreservation and post-thaw recovery of natural killer cells is critical for the success of off-the-shelf platformsJennifer N Saultz, Folashade Otegbeye
Best Practice & Research. Clinical Haematology|April 24, 2025
Creating a GMP cell processing program: A focus on quality and regulationDarshan Patel, Jane Reese Koç, Folashade Otegbeye
Mediterranean Journal of Hematology and Infectious Diseases|May 15, 2018
Perioperative Management of Sickle Cell DiseaseKwame Ofori Adjepong, Folashade Otegbeye, Yaw Amoateng Adjepong
Bone Marrow Transplantation|May 29, 2020
Interrogating the impact of KIR ligand mismatch in engraftment following HLA-disparate stem cell transplantationLucy Li, Merle Kolk, Marcelo Fernandez-Vina, et al.
Cytotherapy|July 1, 2020
Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxideTabatha Trummer, Robert Fox, Jane Reese Koç, et al.
Plos One|January 18, 2018
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer modelsFolashade Otegbeye, Evelyn Ojo, Stephen Moreton, et al.
Plos One|May 3, 2018
Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer modelsFolashade Otegbeye, Evelyn Ojo, Stephen Moreton, et al.
Transplantation and Cellular Therapy|September 4, 2022
Nomenclature for Cellular and Genetic Therapies: A Need for StandardizationAkshay Sharma, Stephanie Farnia, Folashade Otegbeye, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|May 6, 2022
Bench at Bedside Models Facilitate CAR-T Cell Supply ChainFolashade Otegbeye
Revista Brasileira De Hematologia E Hemoterapia|August 24, 2017
Understanding population-wide haplotype frequencies of human leukocyte antigen (HLA) alleles in linkage disequilibrium is important for hematopoietic stem cell transplantationFolashade Otegbeye
Frontiers in Immunology|January 9, 2024
Optimizing the cryopreservation and post-thaw recovery of natural killer cells is critical for the success of off-the-shelf platformsJennifer N Saultz, Folashade Otegbeye
Best Practice & Research. Clinical Haematology|April 24, 2025
Creating a GMP cell processing program: A focus on quality and regulationDarshan Patel, Jane Reese Koç, Folashade Otegbeye
Mediterranean Journal of Hematology and Infectious Diseases|May 15, 2018
Perioperative Management of Sickle Cell DiseaseKwame Ofori Adjepong, Folashade Otegbeye, Yaw Amoateng Adjepong
Bone Marrow Transplantation|May 29, 2020
Interrogating the impact of KIR ligand mismatch in engraftment following HLA-disparate stem cell transplantationLucy Li, Merle Kolk, Marcelo Fernandez-Vina, et al.
Cytotherapy|July 1, 2020
Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxideTabatha Trummer, Robert Fox, Jane Reese Koç, et al.
Plos One|January 18, 2018
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer modelsFolashade Otegbeye, Evelyn Ojo, Stephen Moreton, et al.
Plos One|May 3, 2018
Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer modelsFolashade Otegbeye, Evelyn Ojo, Stephen Moreton, et al.
Transplantation and Cellular Therapy|September 4, 2022
Nomenclature for Cellular and Genetic Therapies: A Need for StandardizationAkshay Sharma, Stephanie Farnia, Folashade Otegbeye, et al.
Pageof 4